GSS 0.00% $2.00 genetic signatures limited

Ann: Investor Presentation, page-2

  1. 464 Posts.
    lightbulb Created with Sketch. 58
    https://hotcopper.com.au/data/attachments/2189/2189379-b5baea5daeeff16b47ee58d6e8777893.jpg

    FDA EUA Clearance for SARS-CoV-2 expected this quarter - We knew that from previous announcement.
    First mention of "First US Customer" for SARS-CoV-2? - great news as they say it'll be first of many in the US market and most likely to move onto other multiplex kits.

    STI-Genital kit is another big step (biggest global addressable market), it'll more than double our revenue once we get the approval.

    https://hotcopper.com.au/data/attachments/2189/2189416-7d875d5814f02bbfcb98c2fb91b77705.jpg Combine this with last quarterly update, indicative revenue for April alone is ~1.7M. With new 3 potential customers in Europe (if all successful), the minimum contracted uptake is greater than $3.7M. Conservative estimate if 1/3 of that revenue falls into Q4, it'll be ~$1.2M. Adding revenue from regular customers for May, June on top of that. You know what I mean I'll stop there...

    I'll be topping up more as i believe we'll see long term uptrend in SP.
 
watchlist Created with Sketch. Add GSS (ASX) to my watchlist
(20min delay)
Last
$2.00
Change
0.000(0.00%)
Mkt cap ! $285.3M
Open High Low Value Volume
$2.00 $2.03 $1.98 $94.18K 47.15K

Buyers (Bids)

No. Vol. Price($)
2 13590 $2.00
 

Sellers (Offers)

Price($) Vol. No.
$2.02 2500 1
View Market Depth
Last trade - 15.59pm 18/09/2020 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.